Waste Management, Inc.

The Stericycle acquisition is expected to drive meaningful cost synergies, improve margins, and expand WM's presence in the medical waste market. Combined with automation targeting $450 million in savings and favorable price/cost dynamics, the deal is seen as a significant long-term earnings catalyst.

Despite optimism around synergies, WM's most recent quarterly revenue of $6.23 billion came in below analyst expectations of $6.28 billion, raising questions about whether the Stericycle integration is delivering the anticipated top-line boost and whether revenue growth assumptions may be too aggressive.

WM trades at a discount relative to historical averages and industry peers, presenting 20–30% upside potential. With conservative EPS estimates and a possible valuation re-rating, the stock is seen as attractively priced given its quality, low-risk profile, and strong growth prospects.

WM's current P/E ratio of 34.2x is considered elevated, leading some analysts to assign a Hold rating and recommend waiting for a pullback to the $200–205 range before initiating a position. The premium multiple leaves limited margin of safety should growth disappoint.

WM's renewable energy and recycling segments are expanding rapidly, with targeted fixed-price sales growth of 70–90% in the near term and significant cost reductions underway. These high-growth ancillary businesses are expected to become increasingly material contributors to overall revenue and profitability.

Analysts at Erste Group Bank trimmed their FY2026 EPS forecast, while Wells Fargo lowered its price target from $273 to $268, reflecting concerns that near-term margin pressures and moderating revenue growth could limit how quickly the renewable and recycling investments translate into earnings accretion.